ROGERS WARRANT: Litigation update
Glen Rogers’ execution is set for May 15 at 6:00 p.m. He currently has a petition pending at the U.S. Supreme Court and an appeal at the Eleventh Circuit.
Glen Rogers’ execution is set for Thursday, May 15, at 6:00 p.m.
As TFDP previously covered, Rogers currently has a petition for writ of certiorari pending at the U.S. Supreme Court. As of this morning, when Rogers filed his Reply in support of his petition, briefing on the petition is complete.
The filings can be accessed on the Court’s docket here.
In addition, Rogers has litigation pending in the federal courts.
On May 2, Rogers filed a motion to disqualify his state court counsel in the U.S. District Court for the Middle District of Florida. On May 5, the Department of Corrections filed its response. On May 6, the federal court entered an Order deferring ruling until after the Florida Supreme Court (FSC) issued its decision on Rogers’ pending appeal. The issue was also raised in the state court litigation related to a conflict with his state court counsel.
On May 8, after the FSC’s decision, Rogers’ counsel filed a Motion to Withdraw, which the federal court construed as a motion to reconsider. On May 9, the federal court directed that the issues be immediately sent to the U.S. Court of Appeals for the Eleventh Circuit for review. Yesterday, the federal court entered a written Order denying the motions.
Today, Rogers filed an Emergency Notice of Appeal to the Eleventh Circuit.
TFDP Prior Coverage of the Rogers Warrant
My thoughts are with everyone involved in the warrant- and execution-related process.
Understanding Variegate Porphyria
An Insight into a Rare Genetic Metabolic Disorder
Variegate Porphyria is a rare genetic metabolic disorder that is often misunderstood and misrepresented. Unlike common misconceptions, Variegate Porphyria is not a blood disease but rather a disorder stemming from the body's inability to properly produce heme, a vital component of hemoglobin.
Nature of Variegate Porphyria
Variegate Porphyria belongs to a group of disorders known as porphyrias, which are caused by deficiencies in enzymes involved in heme production. This condition is characterized by a combination of cutaneous (skin) and neurological symptoms. The disorder is particularly notable for its cutaneous manifestations, which include sensitivity to sunlight, blistering, and scarring.
The South African Mutation: R59W
One of the recognized genetic mutations associated with Variegate Porphyria is the R59W mutation, prevalent in South Africa. This mutation results in specific clinical manifestations and presents unique challenges in diagnosis and management. Individuals with this mutation often experience a distinct set of symptoms related to their condition.
Symptoms and Manifestations
Variegate Porphyria presents with a range of symptoms:
• Cutaneous Symptoms: These include photosensitivity, blistering, and skin fragility, particularly in areas exposed to sunlight.
• Neurological Symptoms: Acute attacks can lead to abdominal pain, vomiting, confusion, and seizures. These symptoms are typically triggered by certain medications, fasting, or infections.
It is crucial to distinguish between Variegate Porphyria and other types of porphyria. Not all porphyrias have the same triggers or manifestations, which is why understanding the specific type is essential for effective management.
Challenges in Testing and Diagnosis
Testing for Variegate Porphyria remains problematic worldwide due to the rarity of the disorder and the complexity of its diagnosis. Accurate diagnosis often requires a combination of genetic testing and biochemical assays to identify enzyme deficiencies. Unfortunately, these tests are not widely available, leading to delays in diagnosis and appropriate treatment.
In conclusion, Variegate Porphyria is a complex genetic metabolic disorder that requires careful management and understanding. Misrepresentations about its nature can lead to inadequate care and complications. It is essential for both medical professionals and patients to have accurate information to navigate the challenges associated with this rare condition.